Imunon raises $10.0M (Jun 2026)
Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial - HarianBasis.co
Imunon is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is currently conducting a trial for ovarian cancer, which is a significant area of need in oncology. This funding will support their efforts to advance their clinical programs.
Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial HarianBasis.co
| Sep 17, 2026 | Wysa | $1.2M | — | India |
| Sep 17, 2026 | Vytalyou | $1.3M | — | India |
| Sep 17, 2026 | Health Force | $4.2M | Seed | Spain |
| Sep 16, 2026 | Eterna Regeneratives | $4.0M | Seed | United Kingdom |
Find the investors behind rounds like this one
You just read who funded Imunon. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.